Affordable Access

Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.

Authors
  • De Placido, Sabino
  • Scambia, Giovanni
  • Di Vagno, Giovanni
  • Naglieri, Emanuele
  • Lombardi, Alessandra Vernaglia
  • Biamonte, Rosalbino
  • Marinaccio, Marco
  • Cartenì, Giacomo
  • Manzione, Luigi
  • Febbraro, Antonio
  • De Matteis, Andrea
  • Gasparini, Gianpietro
  • Valerio, Maria Rosaria
  • Danese, Saverio
  • Perrone, Francesco
  • Lauria, Rossella
  • De Laurentiis, Michele
  • Greggi, Stefano
  • Gallo, Ciro
  • Pignata, Sandro
Type
Published Article
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Date
Jul 01, 2004
Volume
22
Issue
13
Pages
2635–2642
Identifiers
PMID: 15226331
Source
Medline
License
Unknown

Abstract

The present analysis indicates that consolidation with topotecan does not improve PFS for patients with advanced ovarian cancer who respond to initial chemotherapy with carboplatin and paclitaxel.

Report this publication

Statistics

Seen <100 times